Test Code CHLM Chlamydia IgM, Immunofluorescence, Serum
Ordering Guidance
For suspected Chlamydia trachomatis infection, order either CTRNA / Chlamydia trachomatis, Nucleic Acid Amplification, Varies or CGRNA / Chlamydia trachomatis and Neisseria gonorrhoeae, Nucleic Acid Amplification, Varies.
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.3 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Useful For
Assessing IgM antibody levels to aid in the clinical diagnosis of Chlamydia pneumoniae or Chlamydia psittaci infections
Testing Algorithm
This test includes testing for Chlamydia pneumoniae IgM, and Chlamydia psittaci IgM
Method Name
Micro-Immunofluorescent Antibody (MIF) Assay
Reporting Name
Chlamydia IgM, IFA, SSpecimen Type
SerumSpecimen Minimum Volume
0.15 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 30 days | |
Frozen | 30 days |
Reference Values
Chlamydia pneumoniae
<1:10
Chlamydia psittaci
<1:10
Interpretation
Chlamydia pneumoniae, and Chlamydia psittaci
≥1:10
IgM endpoint titers of 1:10 or more are considered presumptive evidence of infection.
<1:10
IgM endpoint titers below 1:10 suggest that the patient does not have a current infection. These antibody levels may be found in patients with either no history of chlamydial infection or those with past infection whose antibody levels have dropped below detectable levels.
Clinical Reference
1. Schlossberg D. Psittacosis (due to Chlamydia psittaci). In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Elsevier; 2020:2320-2322
2. Hammerschlag MR, Kohlhoff SA, Gaydos CA. Chlamydia pneumoniae. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Elsevier; 2020:2323-2331
Day(s) Performed
Monday, Thursday
Report Available
Same day/1 to 4 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
86632 x 2
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CHLM | Chlamydia IgM, IFA, S | 10849-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
619390 | C. pneumoniae IgM | In Process |
619391 | C. psittaci IgM | In Process |